A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

Journal of Human Hypertension

Volumn 15, Issue 3, 2001, Pages 161-167

  Fagard, R ^a   Lijnen, P ^a   Pardaens, K ^a   Thijs, L ^a   Vinck, W ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ambulatory blood pressure; Angiotensin II receptor antagonist; Converting enzyme inhibitor; Enalapril; Losartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LONG TERM CARE; MALE; NIGHT; RANDOMIZED CONTROLLED TRIAL;

EID: 0035127162     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001159     Document Type: Article

References (21)

1. A randomised, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
2. Comparison of the angiotensin II antagonist losartan with the ACE inhibitor enalapril in patients with essential hypertension
3. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension
4. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study
5. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor
6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin-II antagonism on BP and renin release in sodium-depleted normotensives
7. Additive effects of losartan and enalapril on BP and plasma active renin
8. Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory BP monitoring
9. 1999 World Health Organisation - International Society of Hypertension guidelines for the management of hypertension
10. Prediction of the actual awake and asleep BPs by various methods of 24-h pressure analysis
11. Faster radioimmunoassay of angiotensin I at 37°C
12. Spectrophotometric assay of plasma kininase II activity
13. The diurnal BP profile. A population study
14. Blood pressure effects of the angiotensin-II receptor blocker, losartan
15. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
16. Relative value of betablockers and thiazides for initiating antihypertensive therapy
17. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients
18. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
19. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
20. Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
21. Effect of bradykinin-receptor blockade on the response to angiotensin converting enzyme inhibitor in normotensive and hypertensive subjects